Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
InMed Pharmaceuticals Inc. issued up to 153,236 common shares (on a post-consolidation basis) of warrant to affiliates of H.C. Wainwright & Co., LLC for amended the Wainwright Exercise Prices contained in each Wainwright Preferred Investment Option to $0.80.
- Security
- warrant
- Shares
- up to 153,236 common shares (on a post-consolidation basis)
- Purchaser
- affiliates of H.C. Wainwright & Co., LLC
- Consideration
- amended the Wainwright Exercise Prices contained in each Wainwright Preferred Investment Option to $0.80
Exact text from the filing
On April 24, 2026, the Company entered into Preferred Investment Option Amending Agreements (the “Wainwright Preferred Investment Option Amending Agreements”) with each Wainwright Party to amend the Wainwright Exercise Prices contained in each Wainwright Preferred Investment Option to $0.80.
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
InMed Pharmaceuticals Inc. issued up to 2,151,478 common shares of warrant to Sabby Volatility Warrant Master Fund, Ltd. for amended the Sabby Exercise Price contained in each Sabby Preferred Investment Option from $2.436 to $0.80.
- Security
- warrant
- Shares
- up to 2,151,478 common shares
- Purchaser
- Sabby Volatility Warrant Master Fund, Ltd.
- Consideration
- amended the Sabby Exercise Price contained in each Sabby Preferred Investment Option from $2.436 to $0.80
Exact text from the filing
On April 21, 2026, the Company entered into a Preferred Investment Option Amending Agreement (the “Sabby Preferred Investment Option Amending Agreement”) with Sabby to amend the Sabby Exercise Price contained in each Sabby Preferred Investment Option from $2.436 to $0.80.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
InMed Pharmaceuticals Inc. amended Sabby Preferred Investment Option Amending Agreement with Sabby Volatility Warrant Master Fund, Ltd. (effective 2026-04-21).
- Action
- amendment
- Agreement
- equity purchase
- Counterparty
- Sabby Volatility Warrant Master Fund, Ltd.
- Effective
- 2026-04-21
Exact text from the filing
On April 21, 2026, the Company entered into a Preferred Investment Option Amending Agreement (the “Sabby Preferred Investment Option Amending Agreement”) with Sabby to amend the Sabby Exercise Price contained in each Sabby Preferred Investment Option from $2.436 to $0.80.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
InMed Pharmaceuticals Inc. amended Wainwright Preferred Investment Option Amending Agreements with affiliates of H.C. Wainwright & Co., LLC (effective 2026-04-24).
- Action
- amendment
- Agreement
- equity purchase
- Counterparty
- affiliates of H.C. Wainwright & Co., LLC
- Effective
- 2026-04-24
Exact text from the filing
On April 24, 2026, the Company entered into Preferred Investment Option Amending Agreements (the “Wainwright Preferred Investment Option Amending Agreements”) with each Wainwright Party to amend the Wainwright Exercise Prices contained in each Wainwright Preferred Investment Option to $0.80.
View on SEC.gov